One expert is advocating the use of gender-based treatment for mitigating the cardiovascular risk factors related to diabetes. Research has shown women with Type 2 diabetes and high cholesterol are less likely than their male peers to reach treatment goals to lower their bad cholesterol, or low-density lipoprotein (LDL) cholesterol.